✦ LIBER ✦

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate

✍ Scribed by Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Albertina Fanelli; Sara Gentili; Monica Bocchia; Serena Mazzotta; Donatella Raspadori; Francesco Lauria

Book ID: 114135709
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 121 KB
Volume: 148
Category: Article
ISSN: 0165-4608
DOI: 10.1016/s0165-4608(03)00260-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained complete cytogenetic remission

Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy

✍ Seiichi Okabe; Tetsuzo Tauchi; Yuko Ishii; Daigo Akahane; Kousuke Nunoda; Seiko 📂 Article 📅 2007 🏛 Carden Jennings Publishing 🌐 English ⚖ 45 KB

Sequential transient novel chromosomal t

Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate

✍ George Papaioannou; Anastasia Athanasiadou; Georgia Voutiadou; Maria Gaitatzi; I 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 76 KB

Hematopoietic progenitor cell collection

Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy

✍ Bashir, Qaiser; De Lima, Marcos J.; Mcmannis, John D.; Garcia-Manero, Guillermo; 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 196 KB

Emergence of Ph negative clones in chron

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI)

✍ Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Sara Gentili; Monica Bocch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Chronic myeloid leukemia with a novel fo

Chronic myeloid leukemia with a novel four-way t(6;13;9;22)(p21;q32;q34;q11.2) successfully treated with imatinib mesylate

✍ Yoshitsugu Kubota; Masato Waki 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 282 KB

Chronic myelogenous leukemia in T cell l

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy

✍ Ehab Atallah; Moshe Talpaz; Susan O'brien; Mary Beth Rios; Jie Qiang Guo; Ralph 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract ## BACKGROUND A T cell lymphoid blastic phase of chronic myelogenous leukemia (CML) is a rare occurrence, with only a few reported cases worldwide. Standard therapy for such patients is undetermined. Imatinib mesylate, a Bcr‐Abl tyrosine kinase inhibitor, has shown activity in CML. ##